Discovery May Offer Way Around Hormone Therapy Resistance in Prostate Cancer

Discovery May Offer Way Around Hormone Therapy Resistance in Prostate Cancer
A late-stage prostate cancer therapy, being developed by a company founded by researchers at Purdue University, may help to improve outcomes for patients by working to overcome the resistance they often develop to hormone therapy. Prostate cancer depends on the male sex hormone, testosterone, to grow. Hormone therapy, which blocks the production of these hormones (androgens), or their ability to

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Romeao Jennings says:

    I have had metastatic small cell prostate cancer since 1998. I have been through all treatments and now running out of options. How do I get on the list to test this new therapy? PSA is now around 300. I have been resistant for about 4 years now.

Leave a Comment

Your email address will not be published. Required fields are marked *